Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China flag China · Delayed Price · Currency is CNY
22.71
-0.02 (-0.09%)
Aug 3, 2026, 3:00 PM CST

Yifeng Pharmacy Chain Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,7291,6781,5291,4121,262887.88
Depreciation & Amortization
1,7241,7241,8831,6491,4411,191
Other Amortization
239.34239.34264.93182.97145.38117.19
Loss (Gain) From Sale of Assets
-65.46-65.46-46.1-29.09-12.84-6.85
Asset Writedown & Restructuring Costs
14.1214.1218.83--1.43
Loss (Gain) From Sale of Investments
-124.75-124.75-108.13-42.37-6.87-34.37
Provision & Write-off of Bad Debts
0.040.04-2.154.5410.474.41
Other Operating Activities
291.71399.78381.92402.11382.81313.34
Change in Accounts Receivable
169.26169.26-554.45-258.28-1,013-600.7
Change in Inventory
-206.45-206.45-790.97-261.54-459.39-885.07
Change in Accounts Payable
-447.32-447.321,5931,5432,1401,177
Change in Other Net Operating Assets
-21.78-21.7865.4242.423.1619.27
Operating Cash Flow
3,3003,3584,2214,6243,9202,150
Operating Cash Flow Growth
-29.56%-20.44%-8.71%17.95%82.34%-7.71%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-283-322.92-682.67-739.92-587.51-827.54
Sale of Property, Plant & Equipment
24.5324.1866.2715.789.036.52
Cash Acquisitions
-74.65-136.62-254.66-498.82-450.56-408.88
Divestitures
1.21.2----
Investment in Securities
-1,111-1,111-2,811-1,781-250.05632
Other Investing Activities
-95.14118.8473.5123.915.0831.06
Investing Cash Flow
-1,538-1,426-3,609-2,980-1,274-566.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--1,814-80142.12
Long-Term Debt Repaid
--1,554-1,780-1,687-1,483-2,083
Net Debt Issued (Repaid)
-1,492-1,55433.55-1,687-1,403-1,940
Issuance of Common Stock
---7.3977.41-
Repurchase of Common Stock
-0.66-0.66-4-3.52-2.85-1.69
Common Dividends Paid
-858.19-849.31-846.54-321.88-235.02-211.89
Other Financing Activities
-16.23-76.12-103.21-87.91-91.56-30.96
Financing Cash Flow
-2,367-2,480-920.2-2,093-1,655-2,185

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-605.36-547.53-307.78-449.62991-601.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,0173,0363,5393,8843,3331,322
Free Cash Flow Growth
-26.09%-14.22%-8.89%16.53%152.02%-24.30%
Free Cash Flow Margin
12.31%12.42%14.71%17.19%16.76%8.63%
Free Cash Flow Per Share
2.442.462.873.222.751.10
Levered Free Cash Flow
2,2342,5273,2333,2033,1231,096
Unlevered Free Cash Flow
2,3272,6323,3713,3043,2261,201

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,3881,3631,3281,3081,053746.51
Change in Working Capital
-507.19-507.19300.791,045698.37-324.56